NCT01752920 · Interventional trial
Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations
Overall registry status Completed
Phase 1 · Phase 2
Conditions Solid Tumor
Delaware Valley sites
- University of Pennsylvania Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory